Skip to main content
NCBI home page
Canadian Journal of Veterinary Research logoLink to Canadian Journal of Veterinary Research
. 1989 Apr;53(2):147–153.

Urinary excretion of pentoxifylline and its metabolites by standardbred mares.

E C Kwong 1, F C Chen 1, L M Young 1
PMCID: PMC1255539  PMID: 2713780

Abstract

The urinary excretion of a sustained-release formulation of pentoxifylline was studied in the horse after the oral administration of 4.0 grams of Trental tablets. Urine samples were collected for 24 hours after dosing and analyzed for pentoxifylline and its metabolites using high-performance liquid chromatography coupled with an ultraviolet detector. Six metabolites of pentoxifylline were identified in horse urine in addition to less than 0.2% of unchanged drug. Concomitant use of gas chromatography/mass spectrometry allowed for the elucidation of the chemical structures of the metabolites. Metabolism of pentoxifylline yields one demethylated derivative, four hydroxylated metabolites and a conjugate of one of the hydroxymetabolites as urine products. The demethylated derivative, 3-methyl-1-(5-oxohexyl)-xanthine, was found to be the predominant metabolite in the urine.

Full text

PDF
147

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bauza M. T., Smith R. V., Knutson D. E., Witter F. R. Gas chromatographic determination of pentoxifylline and its major metabolites in human breast milk. J Chromatogr. 1984 Sep 14;310(1):61–69. doi: 10.1016/0378-4347(84)80068-7. [DOI] [PubMed] [Google Scholar]
  2. Beermann B., Ings R., Månsby J., Chamberlain J., McDonald A. Kinetics of intravenous and oral pentoxifylline in healthy subjects. Clin Pharmacol Ther. 1985 Jan;37(1):25–28. doi: 10.1038/clpt.1985.6. [DOI] [PubMed] [Google Scholar]
  3. Bryce T. A., Burrows J. L. Determination of oxpentifylline and a metabolite, 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine, by gas--liquid chromatography using a nitrogen-selective detector. J Chromatogr. 1980 Mar 14;181(3-4):355–361. doi: 10.1016/s0378-4347(00)81138-x. [DOI] [PubMed] [Google Scholar]
  4. Bryce T. A., Burrows J. L., Jolley K. W. Determination of 1-(3'-carboxypropyl)-3,7-dimethylxanthine and 1-(4'-carboxybutyl)-3,7-dimethylxanthine, two major metabolites of oxpentifylline, in urine by high-performance liquid chromatography. J Chromatogr. 1985 Nov 8;344:397–402. doi: 10.1016/s0378-4347(00)82047-2. [DOI] [PubMed] [Google Scholar]
  5. CORNISH H. H., CHRISTMAN A. A. A study of the metabolism of theobromine, theophylline, and caffeine in man. J Biol Chem. 1957 Sep;228(1):315–323. [PubMed] [Google Scholar]
  6. Chivers D. A., Birkett D. J., Miners J. O. Simultaneous determination of pentoxifylline and its hydroxy metabolite in plasma by high-performance liquid chromatography. J Chromatogr. 1981 Sep 11;225(1):261–265. doi: 10.1016/s0378-4347(00)80271-6. [DOI] [PubMed] [Google Scholar]
  7. Colles C. M. A preliminary report on the use of warfarin in the treatment of navicular disease. Equine Vet J. 1979 Jul;11(3):187–190. doi: 10.1111/j.2042-3306.1979.tb01338.x. [DOI] [PubMed] [Google Scholar]
  8. Fujimoto K., Yoshida S., Moriyama Y., Sakaguchi T. Absorption, distribution, excretion, and metabolism of 1-(5-oxohexyl) theobromine (BL 191) in rats. Chem Pharm Bull (Tokyo) 1976 Jun;24(6):1137–1145. doi: 10.1248/cpb.24.1137. [DOI] [PubMed] [Google Scholar]
  9. Grasela D. M., Rocci M. L., Jr High-performance liquid chromatographic analysis of pentoxifylline and 1-(5'-hydroxyhexyl)-3,7-dimethylxanthine in whole blood. J Chromatogr. 1987 Aug 7;419:368–374. doi: 10.1016/0378-4347(87)80302-x. [DOI] [PubMed] [Google Scholar]
  10. Hinze H. J., Bedessem G., Söder A. Struktur der Ausscheidungsprodukte des 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthins (BL 191) beim Menschen. Arzneimittelforschung. 1972 Jul;22(7):1144–1151. [PubMed] [Google Scholar]
  11. Hinze H. J. Zur Pharmakokinetik von 3,7-Dimethyl-1-(5-oxo-hexyl)-xanthin (BL 191) am Menschen. Arzneimittelforschung. 1972 Sep;22(9):1492–1495. [PubMed] [Google Scholar]
  12. Luke D. R., Rocci M. L., Jr Determination of pentoxifylline and a major metabolite, 3,7-dimethyl-1-(5'-hydroxyhexyl)xanthine, by high-performance liquid chromatography. J Chromatogr. 1986 Jan 10;374(1):191–195. doi: 10.1016/s0378-4347(00)83270-3. [DOI] [PubMed] [Google Scholar]
  13. Rieck W., Platt D. Determination of 3,7-dimethyl-1-(5-oxohexyl)-xanthine (pentoxifylline) and its 3,7-dimethyl-1-(5-hydroxyhexyl)-xanthine metabolite in the plasma of patients with multiple diseases using high-performance liquid chromatography. J Chromatogr. 1984 Feb 10;305(2):419–427. doi: 10.1016/s0378-4347(00)83356-3. [DOI] [PubMed] [Google Scholar]
  14. Smith R. V., Waller E. S., Doluisio J. T., Bauza M. T., Puri S. K., Ho I., Lassman H. B. Pharmacokinetics of orally administered pentoxifylline in humans. J Pharm Sci. 1986 Jan;75(1):47–52. doi: 10.1002/jps.2600750111. [DOI] [PubMed] [Google Scholar]

Articles from Canadian Journal of Veterinary Research are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES